Quarterly Call Option Transactions in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during . The information is specifically focused on institutions that hold call options of Celldex Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 337,600 | 241,100 | 578,700 | — | 578,700 | |||
| Q4 2021 | 387,800 | 277,500 | 665,300 | 273,300 | 12,800 | 286,100 | 379,200 | |
| Q1 2022 | 6,500 | 16,100 | 22,600 | 488,300 | 0 | 488,300 | -465,700 | |
| Q2 2022 | 970,000 | 1,082,800 | 2,052,800 | 69,000 | 0 | 69,000 | 1,983,800 | |
| Q3 2022 | 81,000 | 3,500 | 84,500 | 1,660,000 | 0 | 1,660,000 | -1,575,500 | |
| Q4 2022 | 29,400 | 231,500 | 260,900 | 2,500 | 0 | 2,500 | 258,400 | |
| Q1 2023 | 144,200 | 0 | 144,200 | 210,600 | 0 | 210,600 | -66,400 | |
| Q2 2023 | 500 | 1,700 | 2,200 | 184,000 | 0 | 184,000 | -181,800 | |
| Q3 2023 | 160,000 | 300,000 | 460,000 | 700 | 0 | 700 | 459,300 | |
| Q4 2023 | 23,100 | 5,200 | 28,300 | 139,100 | 0 | 139,100 | -110,800 | |
| Q1 2024 | — | 165,400 | 0 | 165,400 | -165,400 | |||
| Q2 2024 | 1,300 | 20,300 | 21,600 | 26,600 | 0 | 26,600 | -5,000 | |
| Q3 2024 | 138,000 | 1,366,500 | 1,504,500 | — | 1,504,500 | |||